Clinical stage biotechnology company progressing novel & differentiated therapies for inflammatory and allergic diseases, using both oral and topical routes of delivery.
- Year invested 2014
- Investment Stage Early
- Sectors
- Investment Status Historic
- Associated Team
- Website ziarcopharma.com/
- Company Status Acquired (by Novartis)